Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders

Journal of Endocrinological Investigation

Volumn 23, Issue 11, 2000, Pages 765-770

  Tollin, Steven R ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Bromocriptine; Cabergoline; Dopamine; Hyperprolactinemia; Risperidone

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; ESTROGEN; PROLACTIN; RISPERIDONE; TESTOSTERONE;

ADULT; AMENORRHEA; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERPROLACTINEMIA; HYPOGONADISM; MALE; OLIGOMENORRHEA; PROLACTIN BLOOD LEVEL; PSYCHOSIS; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0034523898     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345068     Document Type: Article

References (25)

1. Management of psychotropic-induced hyperprolactinemia
2. Neuroleptic-induced hyperprolactinemia
3. Clinical experience with risperidone
4. Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects
5. Prolactogenic effects of risperidone in male patients - A preliminary study
6. Prolactin levels in premenopausal women treated with risperidone compared with those of women treated with typical neuroleptics
7. Risperidone-induced prolactin elevations in pre-menopausal women with schizophrenia
8. Hyperprolactinemia and male sexual dysfunction
9. Risperidone-induced galactorrhea associated with a prolactin elevation
10. Risperidone and associated amenorrhea: A report of 5 cases
11. Gonadal axis hormones in male schizophrenic patients during treatment with haloperidol and after switch to risperidone
12. Clozapine and risperidone in chronic schizophrenia: Effects on symptoms, parkinsonian side effects, and neuroendocrine response
13. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea
14. Effect of acute and chronic neuroleptic therapy on serum prolactin levels in men and women of different age groups
15. Prolactin levels and adverse events in patients treated with risperidone
16. Drug therapy. Bromocriptine
17. Bromo-ergocryptine in the treatment of phenothiazine-induced galactorrhea
18. Bromocriptine in the treatment of haloperidol-induced galactorrhea
19. Bromocriptine in the treatment of galactorrhea caused by haloperidol: A case study
20. The effect of amantadine on prolactin levels and galactorrhea on neuroleptic - treated patients
21. Amantadine in the treatment of neuroendocrine side effects of neuroleptics
22. Herbal Medicine (Shakuyaku-kanzo-to) in the treatment of risperidone-induced amenorrhea
23. Implications of not treating hyperprolactinemia
24. Decreased bone mineral density in medicated psychiatric patients
25. Osteoporosis associated with neuroleptic treatment. A case report